In the last 12 months, insiders at PRECISION BIOSCIENCES INC ($DTIL) filed 255 transactions with the SEC: 17 open-market purchases totaling $270,848 and 39 sales totaling $1,067,060. Net insider sentiment: net selling.
PRECISION BIOSCIENCES INC operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Amoroso Michael (President and CEO) — 41 transactions totaling $702,010
- Kelly John Alexander (Chief Financial Officer) — 49 transactions totaling $420,851
- Scimeca Dario (General Counsel and Secretary) — 51 transactions totaling $163,020
- SMITH J. JEFFERSON (Chief Research Officer) — 39 transactions totaling $158,646
- Buehler Kevin (Not found) — 8 transactions totaling $42,204
View all SEC Filings for PRECISION BIOSCIENCES INC (DTIL).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | Amoroso Michael | President and CEO | M | Common Stock | 67797 | $0.00 | 263,951.0000 | 13,256,751 | 34.56% | 0.51% |
| Feb. 17, 2026 | SMITH J. JEFFERSON | Chief Research Officer | M | Restricted Stock Units | 16667 | $0.00 | 33,333.0000 | 13,256,751 | 33.33% | 0.13% |
| Feb. 18, 2026 | SMITH J. JEFFERSON | Chief Research Officer | S | Common Stock | 4925 | $3.84 | 129,857.0000 | 13,256,751 | 3.65% | 0.04% |
| Feb. 17, 2026 | SMITH J. JEFFERSON | Chief Research Officer | M | Common Stock | 16667 | $0.00 | 134,782.0000 | 13,256,751 | 14.11% | 0.13% |
| Feb. 17, 2026 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 16667 | $0.00 | 33,333.0000 | 13,256,751 | 33.33% | 0.13% |
| Feb. 18, 2026 | Scimeca Dario | General Counsel and Secretary | S | Common Stock | 4925 | $3.84 | 56,457.0000 | 13,256,751 | 8.02% | 0.04% |
| Feb. 17, 2026 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 16667 | $0.00 | 61,382.0000 | 13,256,751 | 37.27% | 0.13% |
| Feb. 17, 2026 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 27584 | $0.00 | 55,166.0000 | 13,256,751 | 33.33% | 0.21% |
| Feb. 18, 2026 | Kelly John Alexander | Chief Financial Officer | S | Common Stock | 8149 | $3.84 | 125,883.0000 | 13,256,751 | 6.08% | 0.06% |
| Feb. 17, 2026 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 27584 | $0.00 | 134,032.0000 | 13,256,751 | 25.91% | 0.21% |
| Feb. 17, 2026 | Amoroso Michael | President and CEO | M | Restricted Stock Units | 67797 | $0.00 | 135,593.0000 | 13,256,751 | 33.33% | 0.51% |
| Feb. 18, 2026 | Amoroso Michael | President and CEO | S | Common Stock | 20559 | $3.84 | 243,392.0000 | 13,256,751 | 7.79% | 0.16% |
| Jan. 20, 2026 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 1978 | $0.00 | 0.0000 | 13,256,751 | 100.00% | 0.01% |
| Jan. 20, 2026 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 8425 | $0.00 | 8,425.0000 | 13,256,751 | 50.00% | 0.06% |
| Jan. 20, 2026 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 14908 | $0.00 | 14,907.0000 | 13,256,751 | 50.00% | 0.11% |
| Jan. 20, 2026 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 3888 | $0.00 | 81,186.0000 | 13,256,751 | 5.03% | 0.03% |
| Jan. 20, 2026 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 13900 | $0.00 | 95,086.0000 | 13,256,751 | 17.12% | 0.10% |
| Jan. 20, 2026 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 26575 | $0.00 | 121,661.0000 | 13,256,751 | 27.95% | 0.20% |
| Jan. 21, 2026 | Kelly John Alexander | Chief Financial Officer | S | Common Stock | 15213 | $4.03 | 106,448.0000 | 13,256,751 | 12.50% | 0.11% |
| Jan. 20, 2026 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 3888 | $0.00 | 0.0000 | 13,256,751 | 100.00% | 0.03% |
| Jan. 20, 2026 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 13900 | $0.00 | 13,901.0000 | 13,256,751 | 50.00% | 0.10% |
| Jan. 20, 2026 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 26575 | $0.00 | 26,575.0000 | 13,256,751 | 50.00% | 0.20% |
| Jan. 20, 2026 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 8425 | $0.00 | 38,661.0000 | 13,256,751 | 27.86% | 0.06% |
| Jan. 20, 2026 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 1978 | $0.00 | 30,236.0000 | 13,256,751 | 7.00% | 0.01% |
| Jan. 20, 2026 | Amoroso Michael | President and CEO | M | Restricted Stock Units | 69421 | $0.00 | 69,421.0000 | 13,256,751 | 50.00% | 0.52% |
| Jan. 20, 2026 | Amoroso Michael | President and CEO | M | Restricted Stock Units | 37069 | $0.00 | 37,069.0000 | 13,256,751 | 50.00% | 0.28% |
| Jan. 20, 2026 | Amoroso Michael | President and CEO | M | Restricted Stock Units | 8888 | $0.00 | 0.0000 | 13,256,751 | 100.00% | 0.07% |
| Jan. 22, 2026 | Amoroso Michael | President and CEO | S | Common Stock | 34799 | $4.17 | 196,154.0000 | 13,256,751 | 15.07% | 0.26% |
| Jan. 20, 2026 | Amoroso Michael | President and CEO | M | Common Stock | 69421 | $0.00 | 230,953.0000 | 13,256,751 | 42.98% | 0.52% |
| Jan. 20, 2026 | Amoroso Michael | President and CEO | M | Common Stock | 37069 | $0.00 | 161,532.0000 | 13,256,751 | 29.78% | 0.28% |
| Jan. 20, 2026 | Amoroso Michael | President and CEO | M | Common Stock | 8888 | $0.00 | 124,463.0000 | 13,256,751 | 7.69% | 0.07% |
| Jan. 21, 2026 | Scimeca Dario | General Counsel and Secretary | S | Common Stock | 8854 | $4.03 | 44,715.0000 | 13,256,751 | 16.53% | 0.07% |
| Jan. 20, 2026 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 14908 | $0.00 | 53,569.0000 | 13,256,751 | 38.56% | 0.11% |
| Jan. 20, 2026 | SMITH J. JEFFERSON | Chief Research Officer | M | Common Stock | 2500 | $0.00 | 101,649.0000 | 13,256,751 | 2.52% | 0.02% |
| Jan. 20, 2026 | SMITH J. JEFFERSON | Chief Research Officer | M | Common Stock | 10447 | $0.00 | 112,096.0000 | 13,256,751 | 10.28% | 0.08% |
| Jan. 21, 2026 | SMITH J. JEFFERSON | Chief Research Officer | M | Common Stock | 16219 | $0.00 | 128,315.0000 | 13,256,751 | 14.47% | 0.12% |
| Jan. 21, 2026 | SMITH J. JEFFERSON | Chief Research Officer | S | Common Stock | 10200 | $4.03 | 118,115.0000 | 13,256,751 | 7.95% | 0.08% |
| Jan. 20, 2026 | SMITH J. JEFFERSON | Chief Research Officer | M | Restricted Stock Units | 2500 | $0.00 | 0.0000 | 13,256,751 | 100.00% | 0.02% |
| Jan. 20, 2026 | SMITH J. JEFFERSON | Chief Research Officer | M | Restricted Stock Units | 10447 | $0.00 | 10,447.0000 | 13,256,751 | 50.00% | 0.08% |
| Jan. 20, 2026 | SMITH J. JEFFERSON | Chief Research Officer | M | Restricted Stock Units | 16219 | $0.00 | 16,219.0000 | 13,256,751 | 50.00% | 0.12% |
| Dec. 15, 2025 | Brown Melinda | Director | P | Common Stock | 1381 | $4.97 | 23,346.0000 | 13,256,751 | 6.29% | 0.01% |
| Dec. 16, 2025 | Germano Geno J | Director | P | Common Stock | 3000 | $4.72 | 23,883.0000 | 13,256,751 | 14.37% | 0.02% |
| Dec. 16, 2025 | Frankel Stanley | Director | P | Common Stock | 2700 | $4.70 | 19,478.0000 | 13,256,751 | 16.09% | 0.02% |
| Nov. 3, 2025 | Scimeca Dario | General Counsel and Secretary | S | Common Stock | 665 | $6.49 | 28,258.0000 | 13,256,751 | 2.30% | 0.01% |
| Nov. 2, 2025 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 1835 | $0.00 | 28,923.0000 | 13,256,751 | 6.77% | 0.01% |
| Nov. 2, 2025 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 3605 | $0.00 | 0.0000 | 13,256,751 | 100.00% | 0.03% |
| Nov. 3, 2025 | Kelly John Alexander | Chief Financial Officer | S | Common Stock | 1303 | $6.49 | 77,298.0000 | 13,256,751 | 1.66% | 0.01% |
| Nov. 3, 2025 | Amoroso Michael | President and CEO | S | Common Stock | 3409 | $6.49 | 115,575.0000 | 13,256,751 | 2.87% | 0.03% |
| Nov. 2, 2025 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 3605 | $0.00 | 78,601.0000 | 13,256,751 | 4.81% | 0.03% |
| Nov. 3, 2025 | Amoroso Michael | President and CEO | M | Restricted Stock Units | 9444 | $0.00 | 0.0000 | 13,256,751 | 100.00% | 0.07% |
| Nov. 2, 2025 | Amoroso Michael | President and CEO | M | Common Stock | 9444 | $0.00 | 118,984.0000 | 13,256,751 | 8.62% | 0.07% |
| Nov. 2, 2025 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 1835 | $0.00 | 0.0000 | 13,256,751 | 100.00% | 0.01% |
| Sept. 26, 2025 | Frankel Stanley | Director | P | Common Stock | 2700 | $4.97 | 16,778.0000 | 10,481,931 | 19.18% | 0.03% |
| Sept. 22, 2025 | Brown Melinda | Director | P | Common Stock | 1400 | $4.89 | 21,965.0000 | 10,481,931 | 6.81% | 0.01% |
| July 3, 2025 | Kelly John Alexander | Chief Financial Officer | S | Common Stock | 14827 | $4.26 | 73,485.0000 | 10,481,931 | 16.79% | 0.14% |
| June 25, 2025 | Brown Melinda | Director | P | Common Stock | 1682 | $4.14 | 20,565.0000 | 10,481,931 | 8.91% | 0.02% |
| June 25, 2025 | Buehler Kevin | Director | P | Common Stock | 5076 | $4.16 | 28,137.0000 | 10,481,931 | 22.01% | 0.05% |
| June 2, 2025 | Scimeca Dario | General Counsel and Secretary | A | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 10,481,931 | 9999.99% | 0.48% |
| June 2, 2025 | SMITH J. JEFFERSON | Chief Research Officer | A | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 10,481,931 | 9999.99% | 0.48% |
| June 3, 2025 | Brown Melinda | Not found | A | Restricted Stock Units | 21000 | $0.00 | 21,000.0000 | 10,481,931 | 9999.99% | 0.20% |
| May 27, 2025 | Brown Melinda | Not found | M | Restricted Stock Units | 9826 | $0.00 | 0.0000 | 10,481,931 | 100.00% | 0.09% |
| May 27, 2025 | Brown Melinda | Not found | M | Common Stock | 9826 | $0.00 | 18,883.0000 | 10,481,931 | 108.49% | 0.09% |
| June 3, 2025 | Buehler Kevin | Not found | A | Restricted Stock Units | 21000 | $0.00 | 21,000.0000 | 10,481,931 | 9999.99% | 0.20% |
| May 27, 2025 | Buehler Kevin | Not found | M | Restricted Stock Units | 9826 | $0.00 | 0.0000 | 10,481,931 | 100.00% | 0.09% |
| June 2, 2025 | Kelly John Alexander | Chief Financial Officer | A | Restricted Stock Units | 82750 | $0.00 | 82,750.0000 | 10,481,931 | 9999.99% | 0.79% |
| June 3, 2025 | Frankel Stanley | Not found | A | Restricted Stock Units | 21000 | $0.00 | 21,000.0000 | 10,481,931 | 9999.99% | 0.20% |
| May 27, 2025 | Frankel Stanley | Not found | M | Restricted Stock Units | 9826 | $0.00 | 0.0000 | 10,481,931 | 100.00% | 0.09% |
| May 27, 2025 | Frankel Stanley | Not found | M | Common Stock | 9826 | $0.00 | 14,078.0000 | 10,481,931 | 231.09% | 0.09% |
| June 3, 2025 | Pire Shari Lisa | Not found | A | Restricted Stock Units | 21000 | $0.00 | 21,000.0000 | 10,481,931 | 9999.99% | 0.20% |
| May 27, 2025 | Pire Shari Lisa | Not found | M | Restricted Stock Units | 9826 | $0.00 | 0.0000 | 10,481,931 | 100.00% | 0.09% |
| May 27, 2025 | Pire Shari Lisa | Not found | M | Common Stock | 9826 | $0.00 | 14,028.0000 | 10,481,931 | 233.84% | 0.09% |
| June 3, 2025 | Germano Geno J | Not found | A | Restricted Stock Units | 21000 | $0.00 | 21,000.0000 | 10,481,931 | 9999.99% | 0.20% |
| May 27, 2025 | Germano Geno J | Not found | M | Restricted Stock Units | 9826 | $0.00 | 0.0000 | 10,481,931 | 100.00% | 0.09% |
| May 27, 2025 | Germano Geno J | Not found | M | Common Stock | 9826 | $0.00 | 20,883.0000 | 10,481,931 | 88.87% | 0.09% |
| May 27, 2025 | Buehler Kevin | Not found | M | Common Stock | 9826 | $0.00 | 23,061.0000 | 10,481,931 | 74.24% | 0.09% |
| June 2, 2025 | Amoroso Michael | President and CEO | A | Restricted Stock Units | 203390 | $0.00 | 203,390.0000 | 10,481,931 | 9999.99% | 1.94% |
| March 26, 2025 | Buehler Kevin | Not found | P | Common Stock | 4523 | $4.67 | 13,235.0000 | 10,481,931 | 51.92% | 0.04% |
| March 26, 2025 | Brown Melinda | Not found | P | Common Stock | 1839 | $4.75 | 9,057.0000 | 10,481,931 | 25.48% | 0.02% |
| March 25, 2025 | Germano Geno J | Not found | P | Common Stock | 3250 | $5.30 | 11,057.0000 | 10,481,931 | 41.63% | 0.03% |
| March 21, 2025 | Amoroso Michael | President and CEO | M | Restricted Stock Units | 3417 | $0.00 | 0.0000 | 10,481,931 | 100.00% | 0.03% |
| March 21, 2025 | Amoroso Michael | President and CEO | M | Common Stock | 3417 | $0.00 | 110,504.0000 | 10,481,931 | 3.19% | 0.03% |
| March 24, 2025 | Amoroso Michael | President and CEO | S | Common Stock | 964 | $5.56 | 109,540.0000 | 10,481,931 | 0.87% | 0.01% |
| March 3, 2025 | SMITH J. JEFFERSON | Chief Research Officer | M | Restricted Stock Units | 519 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 3, 2025 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 1702 | $0.00 | 86,256.0000 | 0 | 2.01% | 0.00% |
| March 3, 2025 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 1702 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 4, 2025 | Scimeca Dario | General Counsel and Secretary | S | Common Stock | 272 | $4.91 | 25,000.0000 | 0 | 1.08% | 0.00% |
| March 3, 2025 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 919 | $0.00 | 25,272.0000 | 0 | 3.77% | 0.00% |
| March 3, 2025 | SMITH J. JEFFERSON | Chief Research Officer | M | Common Stock | 519 | $0.00 | 95,890.0000 | 0 | 0.54% | 0.00% |
| March 4, 2025 | SMITH J. JEFFERSON | Chief Research Officer | S | Common Stock | 154 | $4.91 | 95,736.0000 | 0 | 0.16% | 0.00% |
| March 3, 2025 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 919 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 20, 2025 | SMITH J. JEFFERSON | Chief Research Officer | M | Restricted Stock Units | 2500 | $0.00 | 2,500.0000 | 0 | 50.00% | 0.00% |
| Jan. 22, 2025 | Scimeca Dario | General Counsel and Secretary | S | Common Stock | 8928 | $4.79 | 24,353.0000 | 0 | 26.83% | 0.00% |
| Jan. 20, 2025 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 1977 | $0.00 | 1,978.0000 | 0 | 49.99% | 0.00% |
| Jan. 20, 2025 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 8427 | $0.00 | 16,850.0000 | 0 | 33.34% | 0.00% |
| Jan. 20, 2025 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 14908 | $0.00 | 29,815.0000 | 0 | 33.33% | 0.00% |
| Jan. 20, 2025 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 44368 | $0.00 | 84,554.0000 | 0 | 110.41% | 0.00% |
| Jan. 20, 2025 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 3889 | $0.00 | 3,888.0000 | 0 | 50.01% | 0.00% |
| Jan. 20, 2025 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 13904 | $0.00 | 27,801.0000 | 0 | 33.34% | 0.00% |
| Jan. 20, 2025 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 26575 | $0.00 | 53,150.0000 | 0 | 33.33% | 0.00% |
| Jan. 20, 2025 | Amoroso Michael | President and CEO | M | Common Stock | 115388 | $0.00 | 143,925.0000 | 0 | 404.35% | 0.00% |
| Jan. 21, 2025 | Amoroso Michael | President and CEO | S | Common Stock | 36838 | $4.67 | 107,087.0000 | 0 | 25.60% | 0.00% |
| Jan. 20, 2025 | Amoroso Michael | President and CEO | M | Restricted Stock Units | 8888 | $0.00 | 8,888.0000 | 0 | 50.00% | 0.00% |
| Jan. 20, 2025 | Amoroso Michael | President and CEO | M | Restricted Stock Units | 37079 | $0.00 | 74,138.0000 | 0 | 33.34% | 0.00% |
| Jan. 20, 2025 | Amoroso Michael | President and CEO | M | Restricted Stock Units | 69421 | $0.00 | 138,842.0000 | 0 | 33.33% | 0.00% |
| Jan. 20, 2025 | SMITH J. JEFFERSON | Chief Research Officer | M | Common Stock | 29168 | $0.00 | 105,658.0000 | 0 | 38.13% | 0.00% |
| Jan. 22, 2025 | SMITH J. JEFFERSON | Chief Research Officer | S | Common Stock | 10287 | $4.79 | 95,371.0000 | 0 | 9.74% | 0.00% |
| Jan. 20, 2025 | SMITH J. JEFFERSON | Chief Research Officer | M | Restricted Stock Units | 10449 | $0.00 | 20,894.0000 | 0 | 33.34% | 0.00% |
| Jan. 20, 2025 | SMITH J. JEFFERSON | Chief Research Officer | M | Restricted Stock Units | 16219 | $0.00 | 32,438.0000 | 0 | 33.33% | 0.00% |
| Jan. 20, 2025 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 25312 | $0.00 | 33,281.0000 | 0 | 317.63% | 0.00% |
| Dec. 30, 2024 | Germano Geno J | Not found | P | Common Stock | 3605 | $4.49 | 7,807.0000 | 0 | 85.79% | 0.00% |
| Dec. 27, 2024 | Buehler Kevin | Not found | P | Common Stock | 4320 | $4.88 | 8,712.0000 | 0 | 98.36% | 0.00% |
| Dec. 27, 2024 | Kelly John Alexander | Chief Financial Officer | P | Common Stock | 2113 | $4.75 | 40,186.0000 | 0 | 5.55% | 0.00% |
| Dec. 26, 2024 | Brown Melinda | Not found | P | Common Stock | 3016 | $4.55 | 7,218.0000 | 0 | 71.78% | 0.00% |
| Nov. 21, 2024 | Kelly John Alexander | Chief Financial Officer | P | Common Stock | 3000 | $6.76 | 38,073.0000 | 0 | 8.55% | 0.00% |
| Nov. 2, 2024 | Amoroso Michael | President and CEO | M | Restricted Stock Units | 9443 | $0.00 | 9,444.0000 | 0 | 50.00% | 0.00% |
| Nov. 4, 2024 | Scimeca Dario | General Counsel and Secretary | S | Common Stock | 588 | $8.19 | 7,969.0000 | 0 | 6.87% | 0.00% |
| Nov. 2, 2024 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 1836 | $0.00 | 1,835.0000 | 0 | 50.01% | 0.00% |
| Nov. 2, 2024 | Amoroso Michael | President and CEO | M | Common Stock | 9443 | $0.00 | 31,549.0000 | 0 | 42.72% | 0.00% |
| Nov. 4, 2024 | Amoroso Michael | President and CEO | S | Common Stock | 3012 | $8.19 | 28,537.0000 | 0 | 9.55% | 0.00% |
| Nov. 2, 2024 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 3605 | $0.00 | 35,073.0000 | 0 | 11.46% | 0.00% |
| Nov. 2, 2024 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 3605 | $0.00 | 3,605.0000 | 0 | 50.00% | 0.00% |
| Nov. 2, 2024 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 1836 | $0.00 | 8,557.0000 | 0 | 27.32% | 0.00% |
| Aug. 22, 2024 | Scimeca Dario | General Counsel and Secretary | A | Restricted Stock Units | 44723 | $0.00 | 44,723.0000 | 0 | 9999.99% | 0.00% |
| Aug. 22, 2024 | SMITH J. JEFFERSON | Chief Research Officer | A | Restricted Stock Units | 48657 | $0.00 | 48,657.0000 | 0 | 9999.99% | 0.00% |
| Aug. 22, 2024 | Amoroso Michael | President and CEO | A | Restricted Stock Units | 208263 | $0.00 | 208,263.0000 | 0 | 9999.99% | 0.00% |
| Aug. 22, 2024 | Kelly John Alexander | Chief Financial Officer | A | Restricted Stock Units | 79725 | $0.00 | 79,725.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2024 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 301 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 7, 2024 | SMITH J. JEFFERSON | Chief Research Officer | M | Restricted Stock Units | 163 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 7, 2024 | SMITH J. JEFFERSON | Chief Research Officer | M | Common Stock | 163 | $0.00 | 76,540.0000 | 0 | 0.21% | 0.00% |
| June 7, 2024 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 454 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 7, 2024 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 454 | $0.00 | 31,468.0000 | 0 | 1.46% | 0.00% |
| June 10, 2024 | SMITH J. JEFFERSON | Chief Research Officer | S | Common Stock | 50 | $11.79 | 76,490.0000 | 0 | 0.07% | 0.00% |
| June 10, 2024 | Scimeca Dario | General Counsel and Secretary | S | Common Stock | 93 | $11.79 | 6,721.0000 | 0 | 1.36% | 0.00% |
| June 7, 2024 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 301 | $0.00 | 6,814.0000 | 0 | 4.62% | 0.00% |
| June 4, 2024 | Germano Geno J | Not found | A | Restricted Stock Units | 9826 | $0.00 | 9,826.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | Frankel Stanley | Not found | A | Restricted Stock Units | 9826 | $0.00 | 9,826.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | Buehler Kevin | Not found | A | Restricted Stock Units | 9826 | $0.00 | 9,826.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | Brown Melinda | Not found | A | Restricted Stock Units | 9826 | $0.00 | 9,826.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | Wadsworth Samuel C. | Not found | A | Restricted Stock Units | 9826 | $0.00 | 9,826.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | Pire Shari Lisa | Not found | A | Restricted Stock Units | 9826 | $0.00 | 9,826.0000 | 0 | 9999.99% | 0.00% |
| May 8, 2024 | Amoroso Michael | President and CEO | A | Common Stock | 8334 | $12.00 | 22,106.0000 | 0 | 60.51% | 0.00% |
| May 8, 2024 | Scimeca Dario | General Counsel and Secretary | A | Common Stock | 833 | $12.00 | 6,513.0000 | 0 | 14.67% | 0.00% |
| May 8, 2024 | SMITH J. JEFFERSON | Chief Research Officer | A | Common Stock | 833 | $12.00 | 76,377.0000 | 0 | 1.10% | 0.00% |
| May 8, 2024 | Kelly John Alexander | Chief Financial Officer | A | Common Stock | 8334 | $12.00 | 31,014.0000 | 0 | 36.75% | 0.00% |
| May 4, 2024 | Buehler Kevin | Not found | M | Common Stock | 4202 | $0.00 | 4,392.0000 | 0 | 2211.58% | 0.00% |
| May 4, 2024 | Pire Shari Lisa | Not found | M | Restricted Stock Units | 4202 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 4, 2024 | Pire Shari Lisa | Not found | M | Common Stock | 4202 | $0.00 | 4,202.0000 | 0 | 9999.99% | 0.00% |
| May 4, 2024 | Frankel Stanley | Not found | M | Restricted Stock Units | 4202 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 4, 2024 | Brown Melinda | Not found | M | Common Stock | 4202 | $0.00 | 4,202.0000 | 0 | 9999.99% | 0.00% |
| May 4, 2024 | Brown Melinda | Not found | M | Restricted Stock Units | 4202 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 4, 2024 | Germano Geno J | Not found | M | Common Stock | 4202 | $0.00 | 4,202.0000 | 0 | 9999.99% | 0.00% |
| May 4, 2024 | Germano Geno J | Not found | M | Restricted Stock Units | 4202 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 4, 2024 | Frankel Stanley | Not found | M | Common Stock | 4202 | $0.00 | 4,252.0000 | 0 | 8404.00% | 0.00% |
| May 4, 2024 | Wadsworth Samuel C. | Not found | M | Restricted Stock Units | 4202 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 4, 2024 | Wadsworth Samuel C. | Not found | M | Common Stock | 4202 | $0.00 | 4,202.0000 | 0 | 9999.99% | 0.00% |
| May 4, 2024 | Buehler Kevin | Not found | M | Restricted Stock Units | 4202 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 29, 2024 | Kelly John Alexander | Chief Financial Officer | A | Common Stock | 506 | $18.50 | 20,978.0000 | 0 | 2.47% | 0.00% |
| May 1, 2024 | Amoroso Michael | President and CEO | M | Restricted Stock Units | 3417 | $0.00 | 3,417.0000 | 0 | 50.00% | 0.00% |
| May 2, 2024 | Amoroso Michael | President and CEO | S | Common Stock | 1526 | $10.32 | 13,772.0000 | 0 | 9.98% | 0.00% |
| May 1, 2024 | Amoroso Michael | President and CEO | M | Common Stock | 3417 | $0.00 | 15,298.0000 | 0 | 28.76% | 0.00% |
| May 1, 2024 | List Alan | Chief Medical Officer | M | Restricted Stock Units | 982 | $0.00 | 981.0000 | 0 | 50.03% | 0.00% |
| May 2, 2024 | List Alan | Chief Medical Officer | S | Common Stock | 290 | $10.32 | 4,488.0000 | 0 | 6.07% | 0.00% |
| May 1, 2024 | List Alan | Chief Medical Officer | M | Common Stock | 982 | $0.00 | 4,778.0000 | 0 | 25.87% | 0.00% |
| May 1, 2024 | SMITH J. JEFFERSON | Chief Research Officer | M | Restricted Stock Units | 519 | $0.00 | 519.0000 | 0 | 50.00% | 0.00% |
| May 2, 2024 | SMITH J. JEFFERSON | Chief Research Officer | S | Common Stock | 154 | $10.32 | 75,544.0000 | 0 | 0.20% | 0.00% |
| May 1, 2024 | SMITH J. JEFFERSON | Chief Research Officer | M | Common Stock | 519 | $0.00 | 75,698.0000 | 0 | 0.69% | 0.00% |
| Feb. 29, 2024 | SMITH J. JEFFERSON | Chief Research Officer | A | Common Stock | 1006 | $12.42 | 75,179.0000 | 0 | 1.36% | 0.00% |
| May 1, 2024 | Scimeca Dario | General Counsel and Secretary | S | Restricted Stock Units | 918 | $0.00 | 919.0000 | 0 | 49.97% | 0.00% |
| May 2, 2024 | Scimeca Dario | General Counsel and Secretary | S | Common Stock | 272 | $10.32 | 5,680.0000 | 0 | 4.57% | 0.00% |
| May 1, 2024 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 918 | $0.00 | 5,952.0000 | 0 | 18.24% | 0.00% |
| May 1, 2024 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 1702 | $0.00 | 1,702.0000 | 0 | 50.00% | 0.00% |
| May 1, 2024 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 1702 | $0.00 | 22,680.0000 | 0 | 8.11% | 0.00% |
| April 26, 2024 | List Alan | Chief Medical Officer | M | Restricted Stock Units | 868 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 26, 2024 | List Alan | Chief Medical Officer | M | Common Stock | 868 | $0.00 | 4,034.0000 | 0 | 27.42% | 0.00% |
| April 30, 2024 | List Alan | Chief Medical Officer | S | Common Stock | 238 | $10.03 | 3,796.0000 | 0 | 5.90% | 0.00% |
| April 18, 2024 | Kelly John Alexander | Chief Financial Officer | A | Restricted Stock Units | 41705 | $0.00 | 41,705.0000 | 0 | 9999.99% | 0.00% |
| April 18, 2024 | SMITH J. JEFFERSON | Chief Research Officer | A | Restricted Stock Units | 31343 | $0.00 | 31,343.0000 | 0 | 9999.99% | 0.00% |
| April 18, 2024 | Amoroso Michael | President and CEO | A | Restricted Stock Units | 111217 | $0.00 | 111,217.0000 | 0 | 9999.99% | 0.00% |
| April 18, 2024 | Scimeca Dario | General Counsel and Secretary | A | Restricted Stock Units | 25277 | $0.00 | 25,277.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2024 | Amoroso Michael | President and CEO | M | Common Stock | 266720 | $0.00 | 493,823.0000 | 0 | 117.44% | 0.00% |
| Jan. 20, 2024 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 116690 | $0.00 | 614,169.0000 | 0 | 23.46% | 0.00% |
| Jan. 20, 2024 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 116690 | $0.00 | 233,310.0000 | 0 | 33.34% | 0.00% |
| Jan. 22, 2024 | Amoroso Michael | President and CEO | S | Common Stock | 137390 | $0.36 | 356,433.0000 | 0 | 27.82% | 0.00% |
| Jan. 20, 2024 | Amoroso Michael | President and CEO | M | Restricted Stock Units | 266720 | $0.00 | 533,280.0000 | 0 | 33.34% | 0.00% |
| Jan. 20, 2024 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 59345 | $0.00 | 172,315.0000 | 0 | 52.53% | 0.00% |
| Jan. 22, 2024 | Scimeca Dario | General Counsel and Secretary | S | Common Stock | 21287 | $0.36 | 151,028.0000 | 0 | 12.35% | 0.00% |
| Jan. 20, 2024 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 59345 | $0.00 | 118,655.0000 | 0 | 33.34% | 0.00% |
| Jan. 20, 2024 | List Alan | Chief Medical Officer | M | Common Stock | 60012 | $0.00 | 116,508.0000 | 0 | 106.22% | 0.00% |
| Jan. 22, 2024 | List Alan | Chief Medical Officer | S | Common Stock | 21526 | $0.36 | 94,982.0000 | 0 | 18.48% | 0.00% |
| Jan. 20, 2024 | List Alan | Chief Medical Officer | M | Restricted Stock Units | 60012 | $0.00 | 119,988.0000 | 0 | 33.34% | 0.00% |
| Jan. 20, 2024 | SMITH J. JEFFERSON | Chief Research Officer | M | Common Stock | 75015 | $0.00 | 2,253,228.0000 | 0 | 3.44% | 0.00% |
| Jan. 23, 2024 | SMITH J. JEFFERSON | Chief Research Officer | S | Common Stock | 28000 | $0.37 | 2,225,228.0000 | 0 | 1.24% | 0.00% |
| Jan. 20, 2024 | SMITH J. JEFFERSON | Chief Research Officer | M | Restricted Stock Units | 75015 | $0.00 | 149,985.0000 | 0 | 33.34% | 0.00% |
| Nov. 2, 2023 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 108188 | $0.00 | 497,479.0000 | 0 | 27.79% | 0.00% |
| Nov. 2, 2023 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 55077 | $0.00 | 128,993.0000 | 0 | 74.51% | 0.00% |
| Nov. 3, 2023 | Scimeca Dario | General Counsel and Secretary | S | Common Stock | 16023 | $0.40 | 112,970.0000 | 0 | 12.42% | 0.00% |
| Nov. 2, 2023 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 55077 | $0.00 | 110,123.0000 | 0 | 33.34% | 0.00% |
| Nov. 2, 2023 | Amoroso Michael | President and CEO | M | Common Stock | 283390 | $0.00 | 352,128.0000 | 0 | 412.28% | 0.00% |
| Nov. 3, 2023 | Amoroso Michael | President and CEO | S | Common Stock | 125025 | $0.40 | 227,103.0000 | 0 | 35.51% | 0.00% |
| Nov. 2, 2023 | Amoroso Michael | President and CEO | M | Restricted Stock Units | 283390 | $0.00 | 566,610.0000 | 0 | 33.34% | 0.00% |
| Nov. 2, 2023 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 108188 | $0.00 | 216,312.0000 | 0 | 33.34% | 0.00% |
| Aug. 18, 2023 | Kelly John Alexander | Chief Financial Officer | P | Common Stock | 90000 | $0.48 | 383,340.0000 | 0 | 30.68% | 0.00% |
| Aug. 31, 2023 | Kelly John Alexander | Chief Financial Officer | A | Common Stock | 5951 | $0.39 | 389,291.0000 | 0 | 1.55% | 0.00% |
| Aug. 31, 2023 | Scimeca Dario | General Counsel and Secretary | A | Common Stock | 5443 | $0.39 | 73,916.0000 | 0 | 7.95% | 0.00% |
| Aug. 31, 2023 | SMITH J. JEFFERSON | Chief Research Officer | A | Common Stock | 5175 | $0.39 | 2,178,213.0000 | 0 | 0.24% | 0.00% |
| Aug. 18, 2023 | Kelly John Alexander | Chief Financial Officer | A | Common Stock | 90000 | $0.48 | 383,340.0000 | 0 | 30.68% | 0.00% |
| June 7, 2023 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 22727 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 7, 2023 | Barton Shane | VP & Corporate Controller | M | Common Stock | 6060 | $0.00 | 27,502.0000 | 0 | 28.26% | 0.00% |
| June 7, 2023 | Barton Shane | VP & Corporate Controller | M | Restricted Stock Units | 6060 | $0.00 | 6,060.0000 | 0 | 50.00% | 0.00% |
| June 7, 2023 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 34091 | $0.00 | 279,705.0000 | 0 | 13.88% | 0.00% |
| June 7, 2023 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 13635 | $0.00 | 293,340.0000 | 0 | 4.87% | 0.00% |
| June 7, 2023 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 34091 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 7, 2023 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 13635 | $0.00 | 13,635.0000 | 0 | 50.00% | 0.00% |
| June 7, 2023 | SMITH J. JEFFERSON | Chief Research Officer | M | Common Stock | 4872 | $0.00 | 2,173,038.0000 | 0 | 0.22% | 0.00% |
| June 7, 2023 | SMITH J. JEFFERSON | Chief Research Officer | M | Restricted Stock Units | 4872 | $0.00 | 4,872.0000 | 0 | 50.00% | 0.00% |
| June 7, 2023 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 22727 | $0.00 | 72,790.0000 | 0 | 45.40% | 0.00% |
| June 7, 2023 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 9044 | $0.00 | 81,834.0000 | 0 | 12.42% | 0.00% |
| June 8, 2023 | Scimeca Dario | General Counsel and Secretary | S | Common Stock | 13361 | $0.75 | 68,473.0000 | 0 | 16.33% | 0.00% |
| June 7, 2023 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 9044 | $0.00 | 9,045.0000 | 0 | 50.00% | 0.00% |
| May 4, 2023 | Brown Melinda | Director | A | Restricted Stock Units | 126075 | $0.00 | 126,075.0000 | 0 | 9999.99% | 0.00% |
| May 4, 2023 | Germano Geno J | Director | A | Restricted Stock Units | 126075 | $0.00 | 126,075.0000 | 0 | 9999.99% | 0.00% |
| May 4, 2023 | Pire Shari Lisa | Director | A | Restricted Stock Units | 126075 | $0.00 | 126,075.0000 | 0 | 9999.99% | 0.00% |
| May 4, 2023 | Wadsworth Samuel C. | Director | A | Restricted Stock Units | 126075 | $0.00 | 126,075.0000 | 0 | 9999.99% | 0.00% |
| May 4, 2023 | Buehler Kevin | Director | A | Restricted Stock Units | 126075 | $0.00 | 126,075.0000 | 0 | 9999.99% | 0.00% |
| May 4, 2023 | Frankel Stanley | Director | A | Restricted Stock Units | 126075 | $0.00 | 126,075.0000 | 0 | 9999.99% | 0.00% |
| April 27, 2023 | List Alan | Chief Medical Officer | S | Common Stock | 7771 | $0.79 | 56,496.0000 | 0 | 12.09% | 0.00% |
| April 26, 2023 | List Alan | Chief Medical Officer | M | Restricted Stock Units | 26027 | $0.00 | 26,028.0000 | 0 | 50.00% | 0.00% |
| April 26, 2023 | List Alan | Chief Medical Officer | M | Common Stock | 26027 | $0.00 | 64,267.0000 | 0 | 68.06% | 0.00% |
| April 11, 2023 | Buehler Kevin | Director | M | Restricted Stock Units | 5701 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 11, 2023 | Buehler Kevin | Director | M | Common Stock | 5701 | $0.00 | 5,701.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2023 | Amoroso Michael | President and CEO | M | Restricted Stock Units | 102535 | $0.00 | 205,009.0000 | 0 | 33.34% | 0.00% |
| March 21, 2023 | Amoroso Michael | President and CEO | M | Common Stock | 102535 | $0.00 | 115,737.0000 | 0 | 776.66% | 0.00% |
| March 22, 2023 | Amoroso Michael | President and CEO | S | Common Stock | 46999 | $0.82 | 68,738.0000 | 0 | 40.61% | 0.00% |
| March 17, 2023 | Kelly John Alexander | Chief Financial Officer | P | Common Stock | 20000 | $0.86 | 245,614.0000 | 0 | 8.86% | 0.00% |
| Feb. 28, 2023 | SMITH J. JEFFERSON | Chief Research Officer | A | Common Stock | 12157 | $0.95 | 2,152,590.0000 | 0 | 0.57% | 0.00% |
| March 3, 2023 | List Alan | Chief Medical Officer | M | Restricted Stock Units | 29453 | $0.00 | 58,890.0000 | 0 | 100.05% | 0.00% |
| March 6, 2023 | List Alan | Chief Medical Officer | S | Common Stock | 9473 | $1.07 | 38,240.0000 | 0 | 19.85% | 0.00% |
| March 3, 2023 | List Alan | Chief Medical Officer | M | Common Stock | 29453 | $0.00 | 47,713.0000 | 0 | 161.30% | 0.00% |
| Feb. 28, 2023 | Scimeca Dario | General Counsel and Secretary | A | Common Stock | 2163 | $0.95 | 34,677.0000 | 0 | 6.65% | 0.00% |
| March 3, 2023 | Scimeca Dario | General Counsel and Secretary | M | Common Stock | 27558 | $0.00 | 62,235.0000 | 0 | 79.47% | 0.00% |
| March 6, 2023 | Scimeca Dario | General Counsel and Secretary | S | Common Stock | 12172 | $1.07 | 50,063.0000 | 0 | 19.56% | 0.00% |
| March 3, 2023 | Kelly John Alexander | Chief Financial Officer | M | Restricted Stock Units | 51071 | $0.00 | 102,114.0000 | 0 | 33.34% | 0.00% |
| March 3, 2023 | Kelly John Alexander | Chief Financial Officer | M | Common Stock | 51071 | $0.00 | 225,614.0000 | 0 | 29.26% | 0.00% |
| Feb. 28, 2023 | Kelly John Alexander | Chief Financial Officer | A | Common Stock | 11605 | $0.95 | 174,543.0000 | 0 | 7.12% | 0.00% |
| March 3, 2023 | SMITH J. JEFFERSON | Chief Research Officer | M | Restricted Stock Units | 15576 | $0.00 | 31,144.0000 | 0 | 33.34% | 0.00% |
| March 3, 2023 | SMITH J. JEFFERSON | Chief Research Officer | M | Common Stock | 15576 | $0.00 | 2,168,166.0000 | 0 | 0.72% | 0.00% |
| March 3, 2023 | Scimeca Dario | General Counsel and Secretary | M | Restricted Stock Units | 27558 | $0.00 | 55,101.0000 | 0 | 33.34% | 0.00% |
| March 3, 2023 | Barton Shane | VP & Corporate Controller | M | Restricted Stock Units | 12722 | $0.00 | 25,439.0000 | 0 | 33.34% | 0.00% |
| March 3, 2023 | Barton Shane | VP & Corporate Controller | M | Common Stock | 12722 | $0.00 | 21,422.0000 | 0 | 146.23% | 0.00% |
| Jan. 20, 2023 | Barton Shane | VP & Corporate Controller | A | Restricted Stock Units | 70000 | $0.00 | 70,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | Kelly John Alexander | Chief Financial Officer | A | Restricted Stock Units | 350000 | $0.00 | 350,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | SMITH J. JEFFERSON | Chief Research Officer | A | Restricted Stock Units | 225000 | $0.00 | 225,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | Amoroso Michael | President and CEO | A | Restricted Stock Units | 800000 | $0.00 | 800,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | List Alan | Chief Medical Officer | A | Restricted Stock Units | 180000 | $0.00 | 180,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | Scimeca Dario | General Counsel and Secretary | A | Restricted Stock Units | 178000 | $0.00 | 178,000.0000 | 0 | 9999.99% | 0.00% |